{"id":"https://openalex.org/W3017190830","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","title":"Development of Phenylazo Piperidine Triazenes for Initiated Release of Aryl Diazoniums in Physiologically Relevant Conditions","display_name":"Development of Phenylazo Piperidine Triazenes for Initiated Release of Aryl Diazoniums in Physiologically Relevant Conditions","alternate_titles":[],"publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3017190830","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","mag":"3017190830"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2020.34.s1.03678","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3017190830"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008141710","display_name":"Madeline Gladys Morrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madeline Gladys Morrow","raw_affiliation_strings":["University of Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040733428","display_name":"Garrett J. Davis","orcid":"https://orcid.org/0000-0001-7895-9615","observed_orcids":["https://orcid.org/0000-0001-7895-9615"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garrett J. Davis","raw_affiliation_strings":["University of Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075599654","display_name":"John C. Jewett","orcid":"https://orcid.org/0000-0001-5822-4080","observed_orcids":["https://orcid.org/0000-0001-5822-4080"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Jewett","raw_affiliation_strings":["University of Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona","institution_ids":["https://openalex.org/I138006243"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I138006243"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"S1","first_page":"1","last_page":"1"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11611","display_name":"Cyclopropane Reaction Mechanisms","score":0.02800000086426735,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11708","display_name":"Photochromic and Fluorescence Chemistry","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aryl-diazonium-salts","display_name":"aryl diazonium salts","score":0.828000009059906},{"id":"https://openalex.org/keywords/diazotization","display_name":"diazotization","score":0.7369999885559082},{"id":"https://openalex.org/keywords/electronic-substituent-effects","display_name":"substituent electronic effects","score":0.7149999737739563},{"id":"https://openalex.org/keywords/protein-labeling","display_name":"protein labeling","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.8760703802108765},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7887598872184753},{"id":"https://openalex.org/C2776910235","wikidata":"https://www.wikidata.org/wiki/Q18574","display_name":"Reactivity (psychology)","level":3,"score":0.7662308216094971},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.681286096572876},{"id":"https://openalex.org/C2780242487","wikidata":"https://www.wikidata.org/wiki/Q8345458","display_name":"Triazene","level":2,"score":0.6282837986946106},{"id":"https://openalex.org/C149997192","wikidata":"https://www.wikidata.org/wiki/Q2630168","display_name":"Lability","level":2,"score":0.43679070472717285},{"id":"https://openalex.org/C9061509","wikidata":"https://www.wikidata.org/wiki/Q901713","display_name":"Nucleophilic aromatic substitution","level":3,"score":0.4244089722633362},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.37221792340278625},{"id":"https://openalex.org/C75473681","wikidata":"https://www.wikidata.org/wiki/Q188651","display_name":"Photochemistry","level":1,"score":0.3649720549583435},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.3282686471939087},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.27672433853149414},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.20080110430717468},{"id":"https://openalex.org/C135731615","wikidata":"https://www.wikidata.org/wiki/Q658656","display_name":"Nucleophilic substitution","level":2,"score":0.18273508548736572},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2020.34.s1.03678","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.03678","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7062480078","https://openalex.org/W2576410280","https://openalex.org/W3211190524","https://openalex.org/W2318740895","https://openalex.org/W3126539269","https://openalex.org/W2519283548","https://openalex.org/W2092313049","https://openalex.org/W1965979280","https://openalex.org/W2329231786","https://openalex.org/W2608639924"],"abstract_inverted_index":{"Triazenes":[0],"can":[1,25,35,60],"easily":[2,114],"be":[3,36,61,102],"synthesized":[4],"from":[5],"various":[6,64,83,122],"anilines":[7],"via":[8,214],"diazotization":[9],"and":[10,131,152,182,248],"conjugation":[11],"with":[12,72,121,127,216],"secondary":[13],"amines,":[14],"including":[15,66,125],"piperidine.":[16],"Previous":[17,43],"literature":[18],"has":[19,53,224,258],"noted":[20],"that":[21,34,91,142,170,201,223,257],"such":[22],"triazene":[23],"formation":[24],"act":[26],"as":[27,104],"a":[28,92,116,221,253],"protecting":[29],"mechanism":[30],"for":[31,81,107,160,237],"aryl":[32,58,164,176],"diazoniums":[33,59,106],"subsequently":[37],"released":[38,62],"in":[39,45,211,243,267],"highly":[40],"acidic":[41],"conditions.":[42],"work":[44,88],"our":[46,230,268],"own":[47],"lab":[48],"pertaining":[49],"to":[50,101,113,179,229,240,261],"triazabutadienes":[51,265],"(TBDs)":[52],"shown":[54,200],"analogous":[55,259],"reactivity,":[56],"whereas":[57,186],"under":[63],"conditions":[65],"low":[67],"pH,":[68],"or":[69,271],"by":[70],"irradiation":[71,215,247],"UV":[73,219,246],"light.":[74],"Such":[75],"initiated":[76],"release":[77],"shows":[78],"potential":[79,99,191],"advantages":[80],"studying":[82],"biological":[84,108],"systems.":[85],"In":[86],"this":[87],"we":[89,198,233],"show":[90],"class":[93],"of":[94,119,145,155,163,192,206,252],"phenylazo\u2010piperidine":[95],"triazenes":[96,120,158,203,239],"have":[97,168,199],"similar":[98],"utility":[100,251],"used":[103],"protected":[105],"study.":[109],"We":[110,167],"were":[111],"able":[112],"synthesize":[115],"small":[117],"library":[118],"electronic":[123],"properties":[124],"those":[126],"benzene,":[128],"p\u2010nitrobenzene,":[129],"p\u2010benzamide,":[130],"m\u2010methoxy":[132],"substituents,":[133],"among":[134],"others.":[135],"Subsequent":[136],"studies":[137],"on":[138],"these":[139,193,202,238],"compounds":[140],"showed":[141],"the":[143,146,150,156,175,188,235,250],"electronics":[144],"functional":[147],"groups":[148],"alters":[149],"stability":[151],"subsequent":[153],"reactivity":[154,260],"respective":[157],"allowing":[159],"different":[161],"rates":[162],"diazonium":[165,209],"release.":[166],"seen":[169],"decreasing":[171],"electron":[172,189],"density":[173],"within":[174],"ring":[177],"leads":[178],"more":[180],"stable,":[181],"less":[183],"reactive":[184],"triazenes,":[185],"increasing":[187],"donating":[190],"substituents":[194],"increases":[195],"reactivity.":[196],"Furthermore,":[197],"are":[204],"capable":[205],"releasing":[207],"their":[208],"species":[210],"neutral":[212],"pH":[213],"350":[217],"nm":[218],"light,":[220],"phenomenon":[222],"not":[225],"been":[226],"previously":[227,262],"reported":[228,263],"knowledge.":[231],"Lastly,":[232],"report":[234],"ability":[236],"label":[241],"proteins":[242],"situ":[244],"using":[245],"display":[249],"novel":[254],"coumarin":[255,264],"triazine":[256],"developed":[266],"lab.":[269],"Support":[270],"Funding":[272],"Information":[273],"NSF":[274],"CAREER":[275],"Award":[276]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3017190830","counts_by_year":[],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2020-04-24T00:00:00"}
